NICE has issued a final appraisal determination recommending Celgene's Otezla for adults with active psoriatic arthritis, reversing an earlier decision to reject the drug. The oral drug is Celgene ...

Guselkumab treatment was associated with improvements in 3 biomarkers associated with systemic inflammation among patients with plaque psoriasis.

Not everyone who has psoriasis will get psoriatic arthritis, even though the conditions are often related. Psoriasis causes patches of scaly, red, or white skin called plaques. Psoriatic arthritis ...

As the name would imply, this type of arthritis is linked to the autoimmune skin disorder psoriasis ... argued that more active screening of people at high risk of psoriatic arthritis needs ...

Psoriatic arthritis (PsA) is an inflammatory arthritis that causes joint swelling, pain, and stiffness. It's linked to psoriasis, a skin condition causing inflamed, scaly patches on the skin.

According to one estimate, three in 10 people with psoriasis may eventually go on to get psoriatic arthritis. People with PsA don’t always have psoriasis first. But there’s a silver lining ...

In a study of more than 600 psoriatic arthritis (PsA ... mild involvement of both joint disease and psoriasis, comprising 47.4% (cluster 1, n=297) of the population; severe joint disease but ...

2025 SELARSDI is approved for all indications matching the reference product SELARSDI is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase ... or younger and that there was no active comparator.

Although there’s no cure for canine arthritis, certain dog supplements can help soothe the effects of osteoarthritis by easing minor joint pain and improving mobility. Dog supplements for ...